We previously reported a decrease in breast cancer incidence between 2003 and 2006 for only women aged 50 or above in France [1] . The magnitude and timing of decrease varied by age [2] . This was in the context of a substantial reduction in hormonal replacement therapy (HRT) prescriptions after 2001.
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In this update we report that, this decrease has been maintained into 2007 only for the women 55-64 years old. We used the same national data sources on HRT prescribing and on breast cancer in France up to 2007 [2] .
The Recent publication from Sweden also reported a significant decrease in incidence confined to women 50-59 years of age, in the same context of dramatic decline in the use of HRT [3] . Differences between countries may be the reflect of different types of HRT and duration of use.
In France the range of HRT preparations differs from what is found in the United States, but our results indicate also in France a striking correlation between fall in HRT use and the decline in incidence of breast cancer, in women older than 55 years. 
